Borderline ve Malign Over Tümörlü İnfertil Hastaların Yönetimi

Trillsch F, Mahner S, and Ruetzel J, et al (2010) Clinical management of borderline ovarian tumors Expert Rev Anticancer Ther 10(7)n 1115–1124 https://doi.org/10.1586/era.10.90 PMID: 20645700

du Bois A, Ewald-Riegler N, and de Gregorio N, et al (2013) Borderline tumours of the ovary: a cohort study of the Arbeitsgmeinschaft Gynäkologische Onkologie (AGO) Study Group Eur J Cancer 49(8) 1905–1914 https://doi.org/10.1016/j.ejca.2013.01.035 PMID: 23490647

Taylor HC. Malignant and semi malignant tumours of the ovary. Surg Gynecol Obstet 1929;48:240–338.

Scully RE. World Health Organization classification and nomenclature of

ovarian cancer. Natl Cancer Inst Monogr 1975;42:5–7.

Asc G. Serous and mucinous borderline (low malignant potential) tumors of the ovary. Am J Clin Pathol 2005;123:S13–57.

Skirnisdottir I, Garmo H, Wilander E, Holmberg L. Borderline ovarian tumors in Sweden 1960-2005: trends in incidence and age at diagnosis comparedto ovarian cancer. Int J Cancer. 2008;123(8):1897–901. https://doi.org/10.1002/ijc.23724.

Trope CG, Kaern J, Davidson B. Borderline ovarian tumours. Best Pract Res Clin Obstet Gynaecol. 2012;26(3):325–36. https://doi.org/10.1016/j.bpobgyn.2

011.12.006.

Harter P, Gershenson D, Lhomme C et al. Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian tumors of low malignant potential (borderline ovarian tumors). Int J Gynecol Cancer 2014;24:S5–8.

Lesieur B, Kane A, Duvillard P et al. Prognosticvalue of lymph node involvement in ovarian serous borderline tumors. Am JObstet Gynecol 2011;204:438.e1–7.

Gershenson DM, Silva EG, Tortolero-Luna G, et al. Serous borderline tumours of the ovary with noninvasive peritoneal implants. Cancer 1998;83(10):2157e63.

Fotopoulou C, Schumacher G, Schefold JC, et al. Systematic evaluation of the intraoperative tumour pattern in patients with borderline tumour of the ovary. Int J Gynecol Cancer 2009;19(9):1550e5.

Winter WE, Kucera PR, Rodgers W, et al. Surgical staging in patients with ovarian tumours of low malignant potential.Obstet Gynecol 2002;100(4):671e6.

Guvenal T, Dursun P, Hasdemir PS, et al. Effect of surgical staging on 539 patients with borderline ovarian tumours: a Turkish Gynecologic Oncology Group study. Gynecol Oncol 2013;131(3):546e50.

Rao GG, Skinner E, Gehrig PA, et al. Surgical staging of ovarian low malignant potential tumours. Obstet Gynecol 2004; 104(2):261e6.

National Comprehensive Cancer Network NCCN. Guidelines version 2.2011 epithelial ovarian cancer fallopian tube cancer primary peritoneal cancer 12, 2011.

Weinstein D, Polishuk WZ. The role of wedge resection of the ovary as a cause for mechanical sterility. Surg Gynecol Obstet 1975;141:417–8.

Morice P, Camatte S, El Hassan J, Pautier P, Duvillard P, Castaigne D. Clinical outcomes and fertility after conservative treatment of ovarian borderline tumors. Fertil Steril 2001;75:92–6.

Fang et al. The impact of clinicopathologic and surgical factors on relapse and pregnancy in young patients (≤40 years old) with borderline ovarian tumors

BMC Cancer (2018) 18:1147 https://doi.org/10.1186/s12885-018-4932-2

Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers

in 185 Countries. CA Cancer J Clin. 2021;71(3):209-249.

Yi M, Li T, Niu M, et al. Epidemiological trends of women's cancers from 1990 to 2019 at the global, regional, and national levels: a population-based study. Biomarker research. 2021;9(1):55-55.

American Cancer Society. Ovarian cancer. https://www.cancer.org/

content/dam/CRC/PDF/Public/8773.00.pdf.

Kim S-Y, Lee JR. Fertility preservation option in young women with ovarian cancer. Future Oncol. 2016;12(14):1695–1698.

Zapardiel I, Diestro MD, Aletti G. Conservative treatment of early stage ovarian cancer: oncological and fertility outcomes. Eur J Surg Oncol 2014; 40:387–393.

Kajiyama H, Suzuki S, Niimi K, et al. Oncologic and reproductive outcomes of cystectomy as a fertility-sparing treatment for early-stage epithelial ovarian cancer. Int J Clin Oncol 2019; 24:857–862.

Ohara T, Kuji S, Takenaga T, et al. Current state of fertility preservation for adolescent and young adult patients with gynecological cancer. Int J Clin Oncol 2022; 27:25–34.

Gouy S, Saidani M, Maulard A, et al. Staging surgery in early-stage ovarian mucinous tumors according to expansile and infiltrative types. Gynecol Oncol Rep 2017; 22:21–25.

Li T, Liu Y, Xie S, Wang H. Systematic pelvic and para-aortic lymphadenectomy during fertility-sparing surgery in patients with early-stage epithelial ovarian cancer: a retrospective study. Front Oncol 2022; 12:913103.

Minig L, Heitz F, Cibula D, et al. Patterns of lymph node metastases in apparent stage I low-grade epithelial ovarian cancer: a multicenter study. Ann Surg Oncol 2017; 24:2720–2726.

Stewart K, Campbell S, Frumovitz M, et al. Fertility considerations prior to conservative management of gynecologic cancers. Int J Gynecol Cancer 2021; 31:339–344.

Ray-Coquard I, Morice P, Lorusso D, et al. Nonepithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2018; 29:iv1–iv18.

Mahdi H, Swensen RE, Hanna R, et al. Prognostic impact of lymphadenectomy in clinically early stage malignant germ cell tumour of the ovary. Br J Cancer 2011; 105:493–497.

Bergamini A, Luisa FM, Dellino M, et al. Fertility sparing surgery in sex-cord stromal tumors: oncological and reproductive outcomes. Int J Gynecol Cancer 2022; 32:1063–1070.

Karalok A, Turan T, Ureyen I, et al. Prognostic factors in adult granulosa cell tumor: a long follow-up at a single center. Int J Gynecol Cancer 2016; 26:619–625.

Nasioudis D, Kanninen TT, Holcomb K, et al. Prevalence of lymph node metastasis and prognostic significance of lymphadenectomy in apparent early-stage malignant ovarian sex cord-stromal tumors. Gynecol Oncol 2017; 145:243–247.

Whyte JS, Hawkins E, Rausch M, et al. In vivo oocyte retrieval in a young woman with ovarian cancer. Obstet Gynecol 2014;124:484-6.

Lambertini M, Del Mastro L, Pescio MC, et al. Cancer and fertility preservation: international recommendations from an expert meeting. BMC Med 2016;14:1.

Mahajan N. Fertility preservation in female cancer patients: an overview. J Hum Reprod Sci. 2015;8(1):3–13.

Dolmans MM. Recent advances in fertility preservation and counselingfor female cancer patients. Expert Rev Anticancer Ther. 2018; 18(2):115–120.

Morice P, Camatte S, El Hassan J, et al. Clinical outcomes and fertility after conservative treatment of ovarian borderline tumors. Fertil Steril 2001; 75:92–96.

Ditto A, Martinelli F, Lorusso D, et al. Fertility sparing surgery in early stage epithelial ovarian cancer. J Gynecol Oncol 2014; 25:320–327.

Fruscio R, Corso S, Ceppi L, et al. Conservative management of early-stage epithelial ovarian cancer: results of a large retrospective series. Ann Oncol. 2013;24(1):138-144.

Lambertini M, Ginsburg ES, Partridge AH. Update on fertility preservation in young women undergoing breast cancer and ovarian cancer therapy. Curr Opin Obstet Gynecol. 2015;27(1):98–107.

McKenzie ND, Kennard JA, Ahmad S. Fertility preserving options for gynecologic malignancies: a review of current understanding and future directions. Crit Rev Oncol Hematol. 2018;132:116–124.

Trillsch F, Mahner S, and Ruetzel J, et al (2010) Clinical management of borderline ovarian tumors Expert Rev Anticancer Ther 10(7)n 1115–1124 https://doi.org/10.1586/era.10.90 PMID: 20645700

du Bois A, Ewald-Riegler N, and de Gregorio N, et al (2013) Borderline tumours of the ovary: a cohort study of the Arbeitsgmeinschaft Gynäkologische Onkologie (AGO) Study Group Eur J Cancer 49(8) 1905–1914 https://doi.org/10.1016/j.ejca.2013.01.035 PMID: 23490647

Taylor HC. Malignant and semi malignant tumours of the ovary. Surg Gynecol Obstet 1929;48:240–338.

Scully RE. World Health Organization classification and nomenclature of

ovarian cancer. Natl Cancer Inst Monogr 1975;42:5–7.

Asc G. Serous and mucinous borderline (low malignant potential) tumors of the ovary. Am J Clin Pathol 2005;123:S13–57.

Skirnisdottir I, Garmo H, Wilander E, Holmberg L. Borderline ovarian tumors in Sweden 1960-2005: trends in incidence and age at diagnosis comparedto ovarian cancer. Int J Cancer. 2008;123(8):1897–901. https://doi.org/10.1002/ijc.23724.

Trope CG, Kaern J, Davidson B. Borderline ovarian tumours. Best Pract Res Clin Obstet Gynaecol. 2012;26(3):325–36. https://doi.org/10.1016/j.bpobgyn.2

011.12.006.

Harter P, Gershenson D, Lhomme C et al. Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian tumors of low malignant potential (borderline ovarian tumors). Int J Gynecol Cancer 2014;24:S5–8.

Lesieur B, Kane A, Duvillard P et al. Prognosticvalue of lymph node involvement in ovarian serous borderline tumors. Am JObstet Gynecol 2011;204:438.e1–7.

Gershenson DM, Silva EG, Tortolero-Luna G, et al. Serous borderline tumours of the ovary with noninvasive peritoneal implants. Cancer 1998;83(10):2157e63.

Fotopoulou C, Schumacher G, Schefold JC, et al. Systematic evaluation of the intraoperative tumour pattern in patients with borderline tumour of the ovary. Int J Gynecol Cancer 2009;19(9):1550e5.

Winter WE, Kucera PR, Rodgers W, et al. Surgical staging in patients with ovarian tumours of low malignant potential.Obstet Gynecol 2002;100(4):671e6.

Guvenal T, Dursun P, Hasdemir PS, et al. Effect of surgical staging on 539 patients with borderline ovarian tumours: a Turkish Gynecologic Oncology Group study. Gynecol Oncol 2013;131(3):546e50.

Rao GG, Skinner E, Gehrig PA, et al. Surgical staging of ovarian low malignant potential tumours. Obstet Gynecol 2004; 104(2):261e6.

National Comprehensive Cancer Network NCCN. Guidelines version 2.2011 epithelial ovarian cancer fallopian tube cancer primary peritoneal cancer 12, 2011.

Weinstein D, Polishuk WZ. The role of wedge resection of the ovary as a cause for mechanical sterility. Surg Gynecol Obstet 1975;141:417–8.

Morice P, Camatte S, El Hassan J, Pautier P, Duvillard P, Castaigne D. Clinical outcomes and fertility after conservative treatment of ovarian borderline tumors. Fertil Steril 2001;75:92–6.

Fang et al. The impact of clinicopathologic and surgical factors on relapse and pregnancy in young patients (≤40 years old) with borderline ovarian tumors

BMC Cancer (2018) 18:1147 https://doi.org/10.1186/s12885-018-4932-2

Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers

in 185 Countries. CA Cancer J Clin. 2021;71(3):209-249.

Yi M, Li T, Niu M, et al. Epidemiological trends of women's cancers from 1990 to 2019 at the global, regional, and national levels: a population-based study. Biomarker research. 2021;9(1):55-55.

American Cancer Society. Ovarian cancer. https://www.cancer.org/

content/dam/CRC/PDF/Public/8773.00.pdf.

Kim S-Y, Lee JR. Fertility preservation option in young women with ovarian cancer. Future Oncol. 2016;12(14):1695–1698.

Zapardiel I, Diestro MD, Aletti G. Conservative treatment of early stage ovarian cancer: oncological and fertility outcomes. Eur J Surg Oncol 2014; 40:387–393.

Kajiyama H, Suzuki S, Niimi K, et al. Oncologic and reproductive outcomes of cystectomy as a fertility-sparing treatment for early-stage epithelial ovarian cancer. Int J Clin Oncol 2019; 24:857–862.

Ohara T, Kuji S, Takenaga T, et al. Current state of fertility preservation for adolescent and young adult patients with gynecological cancer. Int J Clin Oncol 2022; 27:25–34.

Gouy S, Saidani M, Maulard A, et al. Staging surgery in early-stage ovarian mucinous tumors according to expansile and infiltrative types. Gynecol Oncol Rep 2017; 22:21–25.

Li T, Liu Y, Xie S, Wang H. Systematic pelvic and para-aortic lymphadenectomy during fertility-sparing surgery in patients with early-stage epithelial ovarian cancer: a retrospective study. Front Oncol 2022; 12:913103.

Minig L, Heitz F, Cibula D, et al. Patterns of lymph node metastases in apparent stage I low-grade epithelial ovarian cancer: a multicenter study. Ann Surg Oncol 2017; 24:2720–2726.

Stewart K, Campbell S, Frumovitz M, et al. Fertility considerations prior to conservative management of gynecologic cancers. Int J Gynecol Cancer 2021; 31:339–344.

Ray-Coquard I, Morice P, Lorusso D, et al. Nonepithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2018; 29:iv1–iv18.

Mahdi H, Swensen RE, Hanna R, et al. Prognostic impact of lymphadenectomy in clinically early stage malignant germ cell tumour of the ovary. Br J Cancer 2011; 105:493–497.

Bergamini A, Luisa FM, Dellino M, et al. Fertility sparing surgery in sex-cord stromal tumors: oncological and reproductive outcomes. Int J Gynecol Cancer 2022; 32:1063–1070.

Karalok A, Turan T, Ureyen I, et al. Prognostic factors in adult granulosa cell tumor: a long follow-up at a single center. Int J Gynecol Cancer 2016; 26:619–625.

Nasioudis D, Kanninen TT, Holcomb K, et al. Prevalence of lymph node metastasis and prognostic significance of lymphadenectomy in apparent early-stage malignant ovarian sex cord-stromal tumors. Gynecol Oncol 2017; 145:243–247.

Whyte JS, Hawkins E, Rausch M, et al. In vivo oocyte retrieval in a young woman with ovarian cancer. Obstet Gynecol 2014;124:484-6.

Lambertini M, Del Mastro L, Pescio MC, et al. Cancer and fertility preservation: international recommendations from an expert meeting. BMC Med 2016;14:1.

Mahajan N. Fertility preservation in female cancer patients: an overview. J Hum Reprod Sci. 2015;8(1):3–13.

Dolmans MM. Recent advances in fertility preservation and counselingfor female cancer patients. Expert Rev Anticancer Ther. 2018; 18(2):115–120.

Morice P, Camatte S, El Hassan J, et al. Clinical outcomes and fertility after conservative treatment of ovarian borderline tumors. Fertil Steril 2001; 75:92–96.

Ditto A, Martinelli F, Lorusso D, et al. Fertility sparing surgery in early stage epithelial ovarian cancer. J Gynecol Oncol 2014; 25:320–327.

Fruscio R, Corso S, Ceppi L, et al. Conservative management of early-stage epithelial ovarian cancer: results of a large retrospective series. Ann Oncol. 2013;24(1):138-144.

Lambertini M, Ginsburg ES, Partridge AH. Update on fertility preservation in young women undergoing breast cancer and ovarian cancer therapy. Curr Opin Obstet Gynecol. 2015;27(1):98–107.

McKenzie ND, Kennard JA, Ahmad S. Fertility preserving options for gynecologic malignancies: a review of current understanding and future directions. Crit Rev Oncol Hematol. 2018;132:116–124.